Jamieson Wellness (TSE:JWEL) Issues Quarterly Earnings Results

Jamieson Wellness (TSE:JWEL – Get Free Report) issued its quarterly earnings results on Monday. The company reported C$0.42 earnings per share for the quarter, FiscalAI reports. The firm had revenue of C$203.73 million during the quarter. Jamieson Wellness had a return on equity of 15.93% and a net margin of 8.92%.

Jamieson Wellness Stock Performance

Shares of JWEL stock traded up C$0.02 during mid-day trading on Monday, reaching C$45.71. 261,712 shares of the company’s stock traded hands, compared to its average volume of 161,629. Jamieson Wellness has a 12 month low of C$32.54 and a 12 month high of C$45.88. The firm has a 50 day moving average price of C$45.50 and a two-hundred day moving average price of C$39.81. The firm has a market capitalization of C$1.90 billion, a PE ratio of 24.98 and a beta of 1.31. The company has a debt-to-equity ratio of 93.69, a quick ratio of 1.08 and a current ratio of 3.41.

Jamieson Wellness Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, September 15th were issued a $0.25 dividend. The ex-dividend date of this dividend was Monday, August 31st. This is an increase from Jamieson Wellness’s previous quarterly dividend of $0.23. This represents a $1.00 annualized dividend and a dividend yield of 2.2%. Jamieson Wellness’s dividend payout ratio is presently 50.27%.

Analyst Ratings Changes

Several brokerages have recently issued reports on JWEL. Canadian Imperial Bank of Commerce lowered Jamieson Wellness from an “outperformer” rating to a “tender” rating and raised their target price for the company from C$44.00 to C$45.75 in a research report on Friday, August 7th. National Bank Financial cut shares of Jamieson Wellness from an “outperform” rating to a “tender” rating and reduced their price objective for the company from C$51.00 to C$45.75 in a research note on Monday, August 31st. Canaccord Genuity Group lowered Jamieson Wellness from a “buy” rating to a “hold” rating and boosted their price objective for the stock from C$44.50 to C$45.75 in a report on Monday, August 10th. Royal Bank Of Canada lowered Jamieson Wellness from an “outperform” rating to a “sector perform” rating and dropped their price target for the stock from C$46.00 to C$45.75 in a research note on Monday, August 10th. Finally, Stifel Nicolaus lowered Jamieson Wellness from a “buy” rating to a “hold” rating and increased their price objective for the company from C$45.00 to C$45.75 in a research report on Friday, August 7th. One investment analyst has rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of C$46.07.

Get Our Latest Analysis on Jamieson Wellness

About Jamieson Wellness

(Get Free Report)

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.

Featured Articles

Earnings History for Jamieson Wellness (TSE:JWEL)

Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.